Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Nat Commun. 2019 Sep 16;10(1):4219. doi: 10.1038/s41467-019-11968-2.
Gastroesophageal reflux disease (GERD) is caused by gastric acid entering the esophagus. GERD has high prevalence and is the major risk factor for Barrett's esophagus (BE) and esophageal adenocarcinoma (EA). We conduct a large GERD GWAS meta-analysis (80,265 cases, 305,011 controls), identifying 25 independent genome-wide significant loci for GERD. Several of the implicated genes are existing or putative drug targets. Loci discovery is greatest with a broad GERD definition (including cases defined by self-report or medication data). Further, 91% of the GERD risk-increasing alleles also increase BE and/or EA risk, greatly expanding gene discovery for these traits. Our results map genes for GERD and related traits and uncover potential new drug targets for these conditions.
胃食管反流病(GERD)是由胃酸进入食管引起的。GERD 的患病率很高,是 Barrett 食管(BE)和食管腺癌(EA)的主要危险因素。我们进行了一项大规模的 GERD GWAS 荟萃分析(80265 例病例,305011 例对照),确定了 25 个与 GERD 相关的独立全基因组显著位点。一些涉及的基因是现有的或假定的药物靶点。采用广泛的 GERD 定义(包括通过自我报告或药物数据定义的病例)时,发现的基因座最多。此外,91%的 GERD 风险增加等位基因也会增加 BE 和/或 EA 的风险,极大地扩展了这些疾病的基因发现。我们的研究结果为 GERD 及其相关疾病的基因图谱,并为这些疾病发现了潜在的新药物靶点。
Cancer Epidemiol Biomarkers Prev. 2015-11
Neurogastroenterol Motil. 2017-2
Gastroenterology. 2020-12
J Natl Cancer Inst. 2013-10-29
Clin Gastroenterol Hepatol. 2018-3-15
Nat Rev Gastroenterol Hepatol. 2025-6-18